13 Oct 21 – KCSA Virtual Investor Conference
10:00 A.M. ET
Presentation: Small Pharma’s progress in the development of N,N-dimethyltryptamine (“DMT”) assisted therapy for the treatment of Major Depressive Disorder
Presented by Peter Rands, CEO
Investor sign up: Registration link
For more information about the conference, or to schedule a one-on-one meeting with Small Pharma’s management team, please contact KCSA Strategic Communications at SmallPharmaIR@kcsa.com.